Bryan Jones's most recent trade in Aardvark Therapeutics Inc. was a trade of 1,250 Common Stock done at an average price of $4.2 . Disclosure was reported to the exchange on Oct. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aardvark Therapeutics Inc | Bryan Jones | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.24 per share. | 15 Oct 2025 | 1,250 | 1,250 | - | 4.2 | 5,300 | Common Stock |
| Aardvark Therapeutics Inc | Bryan Jones | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 1,250 | 40,052 | - | - | Stock option (right to buy) | |
| Aardvark Therapeutics Inc | Bryan Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 122,033 | 122,033 | - | - | Stock Option (right to buy) |